NUCYNTA 50 mg Oral Tablet
RxNorm 854142
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 854142 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: NUCYNTA 50 mg Oral Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
PSNPrescribable
Prescribable Name (PSN):
NUCYNTA 50 mg Oral Tablet
(Atom ID: 6370473)
SYPrescribable
Synonym (SY):
Nucynta 50 mg Oral Tablet
(Atom ID: 2976319)
SBDPrescribable
Semantic Branded Drug (SBD):
Tapentadol 50 mg Oral Tablet [Nucynta]
(Atom ID: 2976318)
Patient Education
Tapentadol
Tapentadol tablets are used to treat moderate to severe acute pain (pain that begins suddenly, has a specific cause, and is expected to go away when the cause of the pain is healed). Tapentadol extended-release tablets are used to treat severe neuropathic pain (pain caused by nerve damage) in people who have diabetes. Tapentadol extended-release tablets are only used to treat people who are expected to need medication around-the-clock to relieve pain that cannot be controlled by the use of other pain medications. Tapentadol is in a class of medications called opiate (narcotic) analgesics. It works by changing the way the brain and nervous system respond to pain.
[Learn More]
* Please review the disclaimer below.